US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist

65.350
+0.910+1.41%

Close Dec 20 16:00 ET

65.956
+0.606+0.93%

Post 20:01 ET

202.63BMarket Cap31.49P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-3.62%4.93B

21.75%7.08B

24.13%8.02B

-6.13%5.86B

4.43%5.12B

18.93%5.81B

10.97%6.46B

-2.42%6.24B

-Cash and cash equivalents

-1.52%4.8B

22.10%6.92B

25.82%7.84B

-5.29%5.84B

9.26%4.87B

17.58%5.66B

8.16%6.23B

-2.58%6.17B

-Short-term investments

-45.49%133M

8.11%160M

-21.74%180M

-74.03%20M

-44.55%244M

111.43%148M

277.05%230M

11.59%77M

-Accounts receivable

5.12%11.88B

-0.41%11.05B

7.61%11.07B

16.57%8.41B

21.04%11.3B

24.52%11.09B

18.50%10.29B

19.58%7.21B

-Taxes receivable

139.31%1.67B

87.50%1.58B

126.97%1.15B

95.08%1.43B

-3.86%697M

19.32%840M

38.42%508M

10.26%731M

-Other receivables

----

6.16%2.1B

----

-5.76%1.98B

Inventory

6.99%5.66B

12.20%5.67B

7.45%5.34B

15.43%5.42B

4.21%5.29B

-18.79%5.05B

-34.85%4.97B

-47.69%4.7B

Prepaid assets

----

21.67%1.62B

----

-12.10%1.33B

Restricted cash

----

-37.04%102M

----

--162M

Total current assets

7.35%24.16B

11.18%25.39B

14.95%25.59B

10.89%25.05B

11.26%22.5B

9.19%22.84B

-1.68%22.27B

-13.91%22.59B

Non current assets

Net PPE

18.69%11.51B

12.56%10.83B

10.59%10.62B

11.14%10.5B

5.13%9.7B

-0.03%9.62B

-4.15%9.6B

-7.10%9.45B

-Gross PPE

18.69%11.51B

12.56%10.83B

10.59%10.62B

11.10%19.1B

5.13%9.7B

-0.03%9.62B

-4.15%9.6B

-7.05%17.19B

-Accumulated depreciation

----

-11.06%-8.6B

----

6.98%-7.74B

Goodwill and other intangible assets

5.04%60.53B

3.77%60.49B

-0.81%58.81B

-1.67%58.14B

-2.81%57.63B

-2.40%58.29B

-3.16%59.29B

-5.22%59.13B

-Goodwill

6.02%21.14B

5.51%21.06B

-0.11%19.98B

1.15%20.05B

1.18%19.94B

0.70%19.96B

0.19%20B

-0.89%19.82B

-Other intangible assets

4.53%39.39B

2.87%39.43B

-1.16%38.83B

-3.10%38.09B

-4.79%37.69B

-3.94%38.33B

-4.78%39.29B

-7.27%39.31B

Financial assets

111.26%319M

33.13%217M

83.62%213M

208.11%228M

34.82%151M

44.25%163M

33.33%116M

-27.45%74M

Non current prepaid assets

----

12.76%274M

----

-37.85%243M

Defined pension benefit

----

2.22%92M

----

--90M

Total non current assets

9.76%80.77B

7.11%78.95B

3.06%76.7B

2.94%76.07B

-0.51%73.59B

-2.59%73.7B

-4.13%74.42B

-6.61%73.89B

Total assets

9.20%104.92B

8.08%104.34B

5.80%102.29B

4.80%101.12B

2.02%96.09B

-0.04%96.54B

-3.58%96.69B

-8.43%96.48B

Liabilities

Current liabilities

Payables

6.67%23.15B

5.01%21.99B

4.49%21.33B

30.51%7.62B

15.53%21.71B

11.36%20.94B

7.50%20.41B

-0.29%5.84B

-accounts payable

5.56%21.68B

3.67%20.46B

2.55%19.7B

28.12%3.27B

16.10%20.54B

10.76%19.74B

7.53%19.21B

-9.70%2.55B

-Total tax payable

26.23%1.47B

27.08%1.53B

35.58%1.63B

52.20%2.08B

6.40%1.16B

22.32%1.2B

7.03%1.2B

-1.09%1.36B

-Other payable

----

18.32%2.28B

----

16.44%1.93B

Current provisions

-0.50%1.19B

106.00%1.17B

110.26%1.15B

42.38%1.03B

216.45%1.19B

4.81%567M

-61.63%546M

-5.99%722M

Current debt and capital lease obligation

-72.00%1.57B

11.95%5.36B

64.14%6.33B

-2.56%5.4B

-0.20%5.61B

100.97%4.79B

68.13%3.86B

192.76%5.54B

-Current debt

-76.68%1.25B

11.22%5.07B

66.90%6.05B

-3.48%5.13B

-0.67%5.37B

110.73%4.56B

75.21%3.63B

220.12%5.31B

-Current capital lease obligation

34.89%317M

26.41%292M

21.12%281M

18.86%271M

11.90%235M

5.00%231M

3.11%232M

-2.15%228M

Current liabilities

-9.31%25.93B

8.31%28.57B

16.26%28.9B

16.16%30.54B

15.04%28.59B

20.90%26.38B

9.32%24.86B

16.37%26.29B

Non current liabilities

Long term provisions

-10.60%1.06B

-20.85%1.07B

22.87%1.12B

25.78%1.13B

27.85%1.19B

52.13%1.36B

-3.69%914M

-6.28%896M

Long term debt and capital lease obligation

30.58%29.99B

12.47%28.17B

2.08%28.22B

-1.98%23.22B

-3.01%22.97B

-7.72%25.05B

-4.02%27.65B

-17.99%23.69B

-Long term debt

29.98%28.89B

11.90%27.23B

1.27%27.26B

-2.61%22.37B

-3.42%22.23B

-8.06%24.33B

-4.15%26.92B

-18.37%22.97B

-Long term capital lease obligation

48.52%1.11B

31.44%949M

31.64%961M

18.21%857M

11.38%744M

5.40%722M

0.83%730M

-3.85%725M

Non current accrued expenses

----

-2.70%36M

----

48.00%37M

Derivative product liabilities

-54.67%34M

-10.29%61M

-61.65%51M

-95.97%38M

-74.14%75M

-62.22%68M

182.98%133M

-40.43%943M

Total non current liabilities

26.14%38.19B

10.45%36.18B

-0.35%35.89B

-5.19%31.41B

-11.42%30.28B

-15.62%32.75B

-12.53%36.02B

-23.80%33.13B

Total liabilities

8.92%64.12B

9.50%64.74B

6.43%64.79B

4.25%61.95B

-0.28%58.87B

-2.48%59.13B

-4.75%60.88B

-10.07%59.43B

Shareholders'equity

Share capital

0.26%388M

0.00%387M

-common stock

0.26%388M

0.00%387M

Retained earnings

823.04%3.14B

889.32%1.85B

88.38%-212M

361.67%1.5B

82.44%-434M

85.88%-234M

-48.62%-1.83B

-133.57%-574M

Paid-in capital

0.11%35.2B

0.10%35.2B

0.10%35.19B

0.09%35.34B

0.08%35.17B

0.08%35.16B

0.08%35.31B

Total stockholders'equity

9.47%40.72B

5.67%39.51B

4.63%37.45B

5.69%39.14B

5.87%37.2B

4.06%37.39B

-1.52%35.79B

-5.68%37.04B

Noncontrolling interests

258.33%86M

154.55%56M

9.52%23M

20.00%24M

26.32%24M

15.79%22M

10.53%21M

Total equity

9.63%40.81B

5.83%39.6B

4.72%37.5B

5.69%39.17B

5.88%37.22B

4.07%37.42B

-1.51%35.81B

-5.67%37.06B

Currency Unit

USD

Accounting Standards

NonUS-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-3.62%4.93B	21.75%7.08B	24.13%8.02B	-6.13%5.86B	-6.13%5.86B	4.43%5.12B	18.93%5.81B	10.97%6.46B	-2.42%6.24B	-2.42%6.24B
-Cash and cash equivalents	-1.52%4.8B	22.10%6.92B	25.82%7.84B	-5.29%5.84B	-5.29%5.84B	9.26%4.87B	17.58%5.66B	8.16%6.23B	-2.58%6.17B	-2.58%6.17B
-Short-term investments	-45.49%133M	8.11%160M	-21.74%180M	-74.03%20M	-74.03%20M	-44.55%244M	111.43%148M	277.05%230M	11.59%77M	11.59%77M
-Accounts receivable	5.12%11.88B	-0.41%11.05B	7.61%11.07B	16.57%8.41B	16.57%8.41B	21.04%11.3B	24.52%11.09B	18.50%10.29B	19.58%7.21B	19.58%7.21B
-Taxes receivable	139.31%1.67B	87.50%1.58B	126.97%1.15B	95.08%1.43B	95.08%1.43B	-3.86%697M	19.32%840M	38.42%508M	10.26%731M	10.26%731M
-Other receivables	----	----	----	6.16%2.1B	6.16%2.1B	----	----	----	-5.76%1.98B	-5.76%1.98B
Inventory	6.99%5.66B	12.20%5.67B	7.45%5.34B	15.43%5.42B	15.43%5.42B	4.21%5.29B	-18.79%5.05B	-34.85%4.97B	-47.69%4.7B	-47.69%4.7B
Prepaid assets	----	----	----	21.67%1.62B	21.67%1.62B	----	----	----	-12.10%1.33B	-12.10%1.33B
Restricted cash	----	----	----	-37.04%102M	-37.04%102M	----	----	----	--162M	--162M
Total current assets	7.35%24.16B	11.18%25.39B	14.95%25.59B	10.89%25.05B	10.89%25.05B	11.26%22.5B	9.19%22.84B	-1.68%22.27B	-13.91%22.59B	-13.91%22.59B
Non current assets
Net PPE	18.69%11.51B	12.56%10.83B	10.59%10.62B	11.14%10.5B	11.14%10.5B	5.13%9.7B	-0.03%9.62B	-4.15%9.6B	-7.10%9.45B	-7.10%9.45B
-Gross PPE	18.69%11.51B	12.56%10.83B	10.59%10.62B	11.10%19.1B	11.10%19.1B	5.13%9.7B	-0.03%9.62B	-4.15%9.6B	-7.05%17.19B	-7.05%17.19B
-Accumulated depreciation	----	----	----	-11.06%-8.6B	-11.06%-8.6B	----	----	----	6.98%-7.74B	6.98%-7.74B
Goodwill and other intangible assets	5.04%60.53B	3.77%60.49B	-0.81%58.81B	-1.67%58.14B	-1.67%58.14B	-2.81%57.63B	-2.40%58.29B	-3.16%59.29B	-5.22%59.13B	-5.22%59.13B
-Goodwill	6.02%21.14B	5.51%21.06B	-0.11%19.98B	1.15%20.05B	1.15%20.05B	1.18%19.94B	0.70%19.96B	0.19%20B	-0.89%19.82B	-0.89%19.82B
-Other intangible assets	4.53%39.39B	2.87%39.43B	-1.16%38.83B	-3.10%38.09B	-3.10%38.09B	-4.79%37.69B	-3.94%38.33B	-4.78%39.29B	-7.27%39.31B	-7.27%39.31B
Financial assets	111.26%319M	33.13%217M	83.62%213M	208.11%228M	208.11%228M	34.82%151M	44.25%163M	33.33%116M	-27.45%74M	-27.45%74M
Non current prepaid assets	----	----	----	12.76%274M	12.76%274M	----	----	----	-37.85%243M	-37.85%243M
Defined pension benefit	----	----	----	2.22%92M	2.22%92M	----	----	----	--90M	--90M
Total non current assets	9.76%80.77B	7.11%78.95B	3.06%76.7B	2.94%76.07B	2.94%76.07B	-0.51%73.59B	-2.59%73.7B	-4.13%74.42B	-6.61%73.89B	-6.61%73.89B
Total assets	9.20%104.92B	8.08%104.34B	5.80%102.29B	4.80%101.12B	4.80%101.12B	2.02%96.09B	-0.04%96.54B	-3.58%96.69B	-8.43%96.48B	-8.43%96.48B
Liabilities
Current liabilities
Payables	6.67%23.15B	5.01%21.99B	4.49%21.33B	30.51%7.62B	30.51%7.62B	15.53%21.71B	11.36%20.94B	7.50%20.41B	-0.29%5.84B	-0.29%5.84B
-accounts payable	5.56%21.68B	3.67%20.46B	2.55%19.7B	28.12%3.27B	28.12%3.27B	16.10%20.54B	10.76%19.74B	7.53%19.21B	-9.70%2.55B	-9.70%2.55B
-Total tax payable	26.23%1.47B	27.08%1.53B	35.58%1.63B	52.20%2.08B	52.20%2.08B	6.40%1.16B	22.32%1.2B	7.03%1.2B	-1.09%1.36B	-1.09%1.36B
-Other payable	----	----	----	18.32%2.28B	18.32%2.28B	----	----	----	16.44%1.93B	16.44%1.93B
Current provisions	-0.50%1.19B	106.00%1.17B	110.26%1.15B	42.38%1.03B	42.38%1.03B	216.45%1.19B	4.81%567M	-61.63%546M	-5.99%722M	-5.99%722M
Current debt and capital lease obligation	-72.00%1.57B	11.95%5.36B	64.14%6.33B	-2.56%5.4B	-2.56%5.4B	-0.20%5.61B	100.97%4.79B	68.13%3.86B	192.76%5.54B	192.76%5.54B
-Current debt	-76.68%1.25B	11.22%5.07B	66.90%6.05B	-3.48%5.13B	-3.48%5.13B	-0.67%5.37B	110.73%4.56B	75.21%3.63B	220.12%5.31B	220.12%5.31B
-Current capital lease obligation	34.89%317M	26.41%292M	21.12%281M	18.86%271M	18.86%271M	11.90%235M	5.00%231M	3.11%232M	-2.15%228M	-2.15%228M
Current liabilities	-9.31%25.93B	8.31%28.57B	16.26%28.9B	16.16%30.54B	16.16%30.54B	15.04%28.59B	20.90%26.38B	9.32%24.86B	16.37%26.29B	16.37%26.29B
Non current liabilities
Long term provisions	-10.60%1.06B	-20.85%1.07B	22.87%1.12B	25.78%1.13B	25.78%1.13B	27.85%1.19B	52.13%1.36B	-3.69%914M	-6.28%896M	-6.28%896M
Long term debt and capital lease obligation	30.58%29.99B	12.47%28.17B	2.08%28.22B	-1.98%23.22B	-1.98%23.22B	-3.01%22.97B	-7.72%25.05B	-4.02%27.65B	-17.99%23.69B	-17.99%23.69B
-Long term debt	29.98%28.89B	11.90%27.23B	1.27%27.26B	-2.61%22.37B	-2.61%22.37B	-3.42%22.23B	-8.06%24.33B	-4.15%26.92B	-18.37%22.97B	-18.37%22.97B
-Long term capital lease obligation	48.52%1.11B	31.44%949M	31.64%961M	18.21%857M	18.21%857M	11.38%744M	5.40%722M	0.83%730M	-3.85%725M	-3.85%725M
Non current accrued expenses	----	----	----	-2.70%36M	-2.70%36M	----	----	----	48.00%37M	48.00%37M
Derivative product liabilities	-54.67%34M	-10.29%61M	-61.65%51M	-95.97%38M	-95.97%38M	-74.14%75M	-62.22%68M	182.98%133M	-40.43%943M	-40.43%943M
Total non current liabilities	26.14%38.19B	10.45%36.18B	-0.35%35.89B	-5.19%31.41B	-5.19%31.41B	-11.42%30.28B	-15.62%32.75B	-12.53%36.02B	-23.80%33.13B	-23.80%33.13B
Total liabilities	8.92%64.12B	9.50%64.74B	6.43%64.79B	4.25%61.95B	4.25%61.95B	-0.28%58.87B	-2.48%59.13B	-4.75%60.88B	-10.07%59.43B	-10.07%59.43B
Shareholders'equity
Share capital	0.26%388M	0.26%388M	0.26%388M	0.26%388M	0.26%388M	0.00%387M	0.00%387M	0.00%387M	0.00%387M	0.00%387M
-common stock	0.26%388M	0.26%388M	0.26%388M	0.26%388M	0.26%388M	0.00%387M	0.00%387M	0.00%387M	0.00%387M	0.00%387M
Retained earnings	823.04%3.14B	889.32%1.85B	88.38%-212M	361.67%1.5B	361.67%1.5B	82.44%-434M	85.88%-234M	-48.62%-1.83B	-133.57%-574M	-133.57%-574M
Paid-in capital	0.11%35.2B	0.10%35.2B	0.10%35.19B	0.09%35.34B	0.09%35.34B	0.08%35.17B	0.08%35.16B	0.08%35.16B	0.08%35.31B	0.08%35.31B
Total stockholders'equity	9.47%40.72B	5.67%39.51B	4.63%37.45B	5.69%39.14B	5.69%39.14B	5.87%37.2B	4.06%37.39B	-1.52%35.79B	-5.68%37.04B	-5.68%37.04B
Noncontrolling interests	258.33%86M	258.33%86M	154.55%56M	9.52%23M	9.52%23M	20.00%24M	26.32%24M	15.79%22M	10.53%21M	10.53%21M
Total equity	9.63%40.81B	5.83%39.6B	4.72%37.5B	5.69%39.17B	5.69%39.17B	5.88%37.22B	4.07%37.42B	-1.51%35.81B	-5.67%37.06B	-5.67%37.06B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data

Investment Theme

Infectious Disease

Intraday+0.78%